Agenus
AGEN
#9021
Rank
NZ$0.20 B
Marketcap
NZ$5.61
Share price
-1.78%
Change (1 day)
56.34%
Change (1 year)

Earnings for Agenus (AGEN)

Earnings in 2025 (TTM): NZ$35.28 Million

According to Agenus 's latest financial reports the company's current earnings are NZ$0.10 Billion. In 2024 the company made an earning of -NZ$0.2 Billion, an increase over its 2023 earnings that were of -NZ$0.28 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Agenus from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) NZ$35.28 M-118.16%
2024 -NZ$0.2 Billion-28.13%
2023 -NZ$0.28 Billion-5.5%
2022 -NZ$0.29 Billion-556.26%
2021 NZ$62.71 M-130.37%
2020 -NZ$0.21 Billion73.75%
2019 -NZ$0.12 Billion-48.74%
2018 -NZ$0.24 Billion34.32%
2017 -NZ$0.18 Billion-7.16%
2016 -NZ$0.19 Billion26.55%
2015 -NZ$0.15 Billion110.24%
2014 -NZ$69.88 Million49.12%
2013 -NZ$46.87 Million
2011 -NZ$32.36 Million-12.25%
2010 -NZ$36.88 Million-21.41%
2009 -NZ$46.92 Million-26.86%
2008 -NZ$64.15 Million13.72%
2007 -NZ$56.41 Million-33.4%
2006 -NZ$84.71 Million-31.84%
2005 -NZ$0.13 Billion9.74%
2004 -NZ$0.12 Billion-0.8%
2003 -NZ$0.12 Billion17.37%
2002 -NZ$97.26 Million37.83%
2001 -NZ$70.57 Million55.99%
2000 -NZ$45.24 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$54.91 B 156,682.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$39.13 B 111,645.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$13.61 B 38,776.25%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$15.80 B 45,018.81%๐Ÿ‡ฌ๐Ÿ‡ง UK
Celldex Therapeutics
CLDX
-NZ$0.44 Billion-1,340.09%๐Ÿ‡บ๐Ÿ‡ธ USA